Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
4.160
+0.150 (3.74%)
At close: Dec 20, 2024, 4:00 PM
4.200
+0.040 (0.96%)
After-hours: Dec 20, 2024, 7:47 PM EST

Solid Biosciences Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
88
Market Cap
166.21M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 20228.09M-5.53M-40.57%
Dec 31, 202113.62M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fennec Pharmaceuticals 49.35M
2seventy bio 45.62M
Innate Pharma 36.20M
scPharmaceuticals 30.28M
Elutia 24.78M
Caribou Biosciences 11.48M
TScan Therapeutics 9.36M
Lyell Immunopharma 63.00K
Revenue Rankings